Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals

Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Jacobzone, Stephane (VerfasserIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Paris OECD Publishing 2000
Schriftenreihe:OECD Labour Market and Social Policy Occasional Papers
Schlagworte:
Online-Zugang:UBA01
UBG01
UEI01
UER01
UPA01
UBR01
UBW01
FFW01
FNU01
EUV01
FRO01
FHR01
FHN01
TUM01
FHI01
UBM01
Volltext
Zusammenfassung:Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ...
Beschreibung:1 Online-Ressource (100 Seiten) 21 x 29.7cm
DOI:10.1787/323807375536

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Volltext öffnen